The global cell therapy market is projected to have considerable CAGR of XX% during the forecast period. The market is mainly driven due to the increasing clinical application of cell therapy and growing cell-based research across the globe. Stem cells are unspecialized cells that can divide themselves into indefinite cells and have the potential to produce specialized cells. The appropriate physiological and experimental conditions provided to the unspecialized cells give rise to certain specialized cells, including nerve cells, heart muscle cells, and blood cells. The stem cells have the capability of dividing and renewing themselves over a long period of time. These cells are extensively found in multicellular organisms, wherein mammals, the stem cells are significantly found in two segments: embryonic stem cells and adult stem cells. As the funding on stem cell-based research increases, it is expected to create opportunities for the augmentation of demand in the near future.  

 Segmental Outlook  

The global cell therapy market is segmented on the basis of type and application. Based on the type, the market is further classified into allogeneic and autologous. The autologous segment is projected to have considerable growth owing to the growing application in therapeutics in various diseases such as cancer, musculoskeletal disorder, and others. Based on the application, the global cell therapy market is further segmented into research and therapeutics. The therapeutics segment further segregated into oncology, musculoskeletal disorder, a blood disorder, autoimmune disease, and others. In cancer treatment, the high doses of chemo and radiation therapy are used for cell transplant which is generally of two types, autologous and allogeneic. In autologous type, the stem cell comes from the same person, while in case of the allogeneic process the stem cells come either from the matched or the unmatched donor.

 Global Cell therapy Market Share by Application, 2018(%)

Global Cell therapy market to be driven by Therapeutics Application

The therapeutics application segment held a considerable share in the market owing to the growing application of autologous cell therapy in the treatment of oncology, musculoskeletal disorder, blood disorder, autoimmune disease, and others. Furthermore, the increasing prevalence of chronic diseases such as cancer across the globe contributing to the growth of the market. Cancer is the second leading cause of fatalities around the globe, according to WHO, cancer was responsible for around 9.6 million mortalities in 2018. Moreover, one out of every 6 mortalities across the globe occurs due to cancer. The most common types of cancers due to which the mortality has increased significantly include lung cancer (1.76 million mortality), colorectal cancer (862,000), stomach cancer (783,000), liver cancer (782,000 mortality), and breast cancer (627,000 mortality).

Regional Outlook 

Geographically, the global cell therapy market is further classified into North America, Europe, Asia-Pacific and the Rest of the World. Asia-Pacific is estimated to have considerable market growth in the global market during the forecast period. The market growth in the region is increasing owing to the high prevalence of different types of cancer, rising drug discovery initiatives among pharmaceuticals and biotechnology companies in the region. The major countries which will have a significant market share during the forecast period are India, China, and Japan. Apart from these nations, South Korea and Singapore are some of the other major economies where considerable growth would be observed.

Global Cell therapy Market Growth, by Region 2019-2025

North America to hold a considerable share in the global Cell therapy market

Geographically, North America is projected to hold a significant market share in the global cell therapy market. Major economies which are anticipated to contribute to the North America cell harvesting market are the US and Canada. Rising R&D in cancer research, stem cell technologies, and drug screening & development in the pharmaceutical industry are driving market growth in this region. The government sector and the private sector of the US are investing in the R&D of the healthcare sector which is driving the market of the US. Cell therapy techniques could prove out to be the better alternative for the conventional treatment of cancer in the country. Therefore, there is a range of stem cell research institute in the country that has started focusing on carrying research with cell harvesting procedures.

Market Players Outlook

The key players in the Cell therapy market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Anterogen Co., Ltd., apceth Biopharma GmbH, Astellas Pharma Inc., MEDIPOST Co., Ltd., Osiris Therapeutics, Inc., 7.14. Pharmicell Co., Inc. and others. These market players adopt various strategies such as product launch, partnerships, collaborations, mergers, and acquisitions to sustain a strong position in the market. 

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global cell therapy market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.